Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Akebia Therapeutics Inc. buy yester

Akebia Therapeutics Inc.
Start price
€2.86
23.01.21 / 0%
Target price
€3.00
23.01.22
Performance (%)
-38.46%
End price
€1.76
24.01.22
Summary
This prediction ended on 24.01.22 with a price of €1.76. Massive losses of -38.46% were the result for the BUY prediction by yester.
Performance without dividends (%)
Name 1w 1m 1y 3y
Akebia Therapeutics Inc. -3.513% -3.513% 49.456% -53.881%
iShares Core DAX® 0.961% -2.210% 12.839% 17.154%
iShares Nasdaq 100 2.626% -1.918% 38.498% 45.463%
iShares Nikkei 225® 0.217% -7.216% 19.425% 5.076%
iShares S&P 500 1.540% -1.858% 27.801% 42.583%

According to yester what are the pros and cons of Akebia Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons
Higher risks for its business

Comments by yester for this prediction

In the thread Akebia Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -38.46%
Target price 5.000
Change
Ends at 23.01.22

Buy mit Kursziel 5,0

yester 
0
Report Share
23.01.21
Prediction Buy
Perf. (%) -38.46%
Target price 6.000
Change
Ends at 23.01.22

Kursziel geändert auf 6,0

yester 
0
Report Share
07.02.21
Prediction Buy
Perf. (%) -38.46%
Target price 5.000
Change
Ends at 23.01.22

Kursziel geändert auf 5,0

yester 
0
Report Share
21.03.21
Prediction Buy
Perf. (%) -38.46%
Target price 3.000
Change
Ends at 23.01.22

Kursziel geändert auf 3,0

yester 
0
Report Share
07.04.21
In the thread Trading Akebia Therapeutics Inc.
Prediction Buy
Perf. (%) -38.46%
Target price 3.000
Change
Ends at 23.01.22

Die von yester gewählte maximale Laufzeit wurde überschritten

yester 
0
Report Share
24.01.22